Takeda Pharmaceutical

Takeda Pharmaceutical is a purpose-driven, global biopharmaceutical leader with a mission to create better health for people and a brighter future for the world. Its strategy is built on a balanced, diverse portfolio across five core therapeutic areas and a commitment to translating advanced science into life-transforming treatments. The company's 2019 acquisition of Shire plc was a pivotal event, establishing its leadership in rare diseases and significantly expanding its global footprint. Takeda is now executing a transformation to strengthen competitiveness and accelerate future growth, focusing on innovation, operational excellence, and sustainability.

A multi-modality R&D platform encompassing plasma-derived therapy innovation, biologics and antibody engineering, small molecule discovery, cell and gene therapy capabilities, and integrated data science and digital health technologies.